Adamson Adewole S
Department of Dermatology, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
Adv Exp Med Biol. 2017;1027:79-92. doi: 10.1007/978-3-319-64804-0_8.
Atopic dermatitis (AD) is a chronic inflammatory disorder that affects over 30 million people in the United States of America. Given the large and growing prevalence of AD, the associated economic burden is significant. It has been estimated that AD costs over $5 billion dollars annually. These costs include both direct and indirect costs. Direct costs include prescription medicines, visits to health care providers, hospitalizations, and transportation. Indirect costs include missed days or lost productivity at work or school, career modification, and reduced quality of life. Understanding and measuring these costs can be accomplished through rigorous economic evaluation, which is the organized process of considering inputs and outcomes of various activities. Economic evaluation has been used to contextualize the burden of AD in society. It has also been used to inform patients, providers, and other stakeholders on how to deliver the most evidence-based, efficient care possible. Understanding the economic impact of atopic dermatitis is an important aspect of delivering high quality care.
特应性皮炎（AD）是一种慢性炎症性疾病，在美国影响着超过3000万人。鉴于AD的患病率高且呈上升趋势，其相关的经济负担十分巨大。据估计，AD每年的花费超过50亿美元。这些费用包括直接成本和间接成本。直接成本包括处方药、看医疗保健提供者的费用、住院费用和交通费用。间接成本包括工作或学校的缺勤天数或生产力损失、职业调整以及生活质量下降。通过严格的经济评估可以了解和衡量这些成本，经济评估是考虑各种活动的投入和结果的有组织的过程。经济评估已被用于将AD在社会中的负担情况化。它还被用于告知患者、医疗服务提供者和其他利益相关者如何提供最基于证据、最有效的护理。了解特应性皮炎的经济影响是提供高质量护理的一个重要方面。
